About this event

  • Date and time Wed 29 Apr 2020 from 11:30am to 12:30pm
  • Location Online
  • Organised by Rheumatology and Rehabilitation

This webinar will inform you of the niche role rheumatology drugs can play in the treatment of various stages of COVID-19.  

Recently a number of drugs, which have been used in rheumatology for decades, have been found to be beneficial in the various stages of COVID-19, according to case reports and limited studies.

This webinar will look at the evidence behind these reports and studies, and the new trials which will involve the use of these drugs.

This is a truly unique webinar of profound importance for clinicians battling COVID-19 on the frontlines with little or no pharmaceutical options to date, to affect disease length and severity of the pandemic. 


Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM.


Special rates for difficult times

The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s COVID-19 online events are available free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.


*Please note: Once you have booked you will receive the webinar link on the day of the webinar.


Join in the conversation online
Follow us on Twitter: @RoySocMed

Key speakers

Prof David Isenberg

Professor David Isenberg

Arthritis Research UK Diamond Jubilee Professor of Rheumatology, and Academic Director of the UCL Centre for Rheumatology and Bloomsbury Rheumatology Unit, London


Speaker's biography

Professor Isenberg's major research interests include the structure, function, origin and pathogenecity of anti-DNA antibodies and antiphospholipid antibodies. Also long-term evaluation through the establishment of "tools" used to assess patients with Systemic Lupus Erythematosus, Myositis, and Sjogren's Syndrome.


After gaining his MD in 1984, he held a research fellowship at Boston University where his interest in autoantibody structure/function originated, developing into a specialist involvement in autoimmune rheumatic diseases, notably systemic lupus erythematosus, Sjögren's syndrome, myositis and the anti-phospholipid antibody syndrome. He was appointed Professor in 1981. Since receiving the Arthritis Research UK's Diamond Jubilee Chair of Rheumatology at UCL London in 1996, he has been past President of the British Society for Rheumatology, and elected to Fellowships of both the Royal College of Physicians and the Academy of Medical Sciences. 



Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member